IIQ.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 31, 2025
Report Source: 2025 2nd Quarter Report
INOVIQ Ltd. Stock Analysis IIQ.AX
INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. The firm's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The firm is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.
Read More INOVIQ Ltd (IIQ.AX) Chart
Key Statistics of INOVIQ Ltd (IIQ.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.32Volume
56.33KP/E Ratio (TTM)
-52 Week Range
Market Cap
47.86MAvg. Volume
19.16KDividend Yield
-Financial Metrics & Statements of INOVIQ Ltd (IIQ.AX)
FAQ's for INOVIQ Ltd (IIQ.AX)
- According to Musaffa’s Shariah screening methodology, INOVIQ Ltd (IIQ.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.